Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityOther Accumulated ExpensesPayablesPrepaid AssetsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Marker Therapeutics (MRKR) Other Non-Current Assets (2021 - 2022)

Historic Other Non-Current Assets for Marker Therapeutics (MRKR) over the last 3 years, with Q4 2022 value amounting to $17.8 million.

  • Marker Therapeutics' Other Non-Current Assets rose 151844.81% to $17.8 million in Q4 2022 from the same period last year, while for Dec 2022 it was $17.8 million, marking a year-over-year increase of 151844.81%. This contributed to the annual value of $17.8 million for FY2022, which is 151844.81% up from last year.
  • According to the latest figures from Q4 2022, Marker Therapeutics' Other Non-Current Assets is $17.8 million, which was up 151844.81% from $200000.0 recorded in Q1 2022.
  • In the past 5 years, Marker Therapeutics' Other Non-Current Assets ranged from a high of $17.8 million in Q4 2022 and a low of $200000.0 during Q1 2022